BioLife Solutions (BLFS) Appoints Timothy L. Moore to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
BioLife Solutions Appoints Cell Therapy Executive Timothy L. Moore to its Board of Directors
August 25, 2022 8:03 AM EDTIndustry veteran brings extensive technical operations scale-up experience and extreme fluency in cell therapy tools and services selection process
BOTHELL, Wash., Aug. 25, 2022 /PRNewswire/ --Â BioLife Solutions, Inc. (NASDAQ: BLFS)Â ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies ("CGT") and the broader biopharma markets, today announced the appointment of Timothy L. Moore to its board of... More
